HCA Healthcare, Inc. provided earning guidance for 2024. For the period, the company expects revenues in the range of $67.75 to $70.25 billion, Net Income Attributable to HCA Healthcare, Inc. in the range of $5.20 to $5.60 billion and EPS (diluted) in the range of $19.70 to $21.20 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
318.9 USD | +0.61% |
|
+0.63% | +17.82% |
07-12 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
07-09 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.82% | 83.53B | |
-23.94% | 75.4B | |
+2.32% | 26.73B | |
-4.75% | 18.25B | |
+6.98% | 18.12B | |
+7.77% | 16.51B | |
+82.69% | 14.05B | |
+76.51% | 13.03B | |
-27.89% | 12.67B | |
+20.62% | 12.31B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- HCA Healthcare, Inc. Provides Earning Guidance for 2024